As will be seen below in the GSH-pull down assay (Figure 7E), the properties of 75S particles produced in GSH-depleted HeLa cells are indeed different from those made in untreated HeLa cells
Cell 181(4):914.e10-921.e10 Casalino L, Gaieb Z, Dommer AC, Harbison AM, Fogarty CA, Barros EP, Taylor BC, Fadda E, Amaro RE (2020) Shielding and beyond: the roles of glycans in SARS-CoV-2 spike protein
Here, we present ProTox-II that incorporates molecular similarity, pharmacophores, fragment propensities and machine-learning models for the prediction of various toxicity endpoints
Biomimetic Hydrogel Scaffolds with Copper Peptide-Functionalized RADA16 Nanofiber Improve Wound Healing in Diabetes